CONCLUSION:
We present the first prediction model for histopathological adenomyosis diagnosis. In future, this tool can be useful for both patients and clinicians, with a potential to reduce morbidity and to contribute to shared decision making. Since patient management depends on several factors, such as age, symptoms, and comorbidity, the clinical use of the predicted risks from the proposed model should still be decided on an individual basis. Thus, before steps are made for use in clinical practise, external validation of the model is needed.
CONFLICTS OF INTEREST: None of the authors have any relevant conflicts of interest to disclose.